Skip to main content
Clinical Trials/NCT04100499
NCT04100499UnknownNot Applicable

Evaluation of Adjunctive Use of EndoAnchors During of After EVAR and TEVAR

Hospital Universitario Ramon y Cajal1 site in 1 country300 target enrollmentStarted: December 31, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Rate of participants with type IA Endoleaks

Study Overview

Brief Summary

EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed described to improve fixation (mimicking an open surgical anastomosis) during or after EVAR/TEVAR.

The investigators want to describe the outcomes of all consecutive patients treated with this device (retrospective and prospective data - observational study)

Detailed Description

EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed designed to improve the Endovascular aortic repair. This device is described to mimic an open surgical anastomosis during or after EVAR/TEVAR.

The investigators want to describe the outcomes of all consecutive patients treated with this device (retrospective and prospective data - observational study), these outcomes will be described in terms of type IA Endoleaks, migration and sac regression.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Other

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All consecutive patients with adjunctive use of EndoAnchors during or after EVAR and TEVAR

Exclusion Criteria

  • Patients that don't want te receive any repair for their disease

Outcomes

Primary Outcomes

Rate of participants with type IA Endoleaks

Time Frame: Three years

Absence of type IA Endoleaks during follow-up

Secondary Outcomes

  • Rate of participants with Endograft Migration(Three years)
  • Rate of participants with Sac regression(Three years)

Investigators

Sponsor
Hospital Universitario Ramon y Cajal
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andrés Reyes Valdivia

Principal Investigator

Hospital Universitario Ramon y Cajal

Study Sites (1)

Loading locations...

Similar Trials